Abstract

BackgroundPichia pastoris (syn. Komagataella phaffii) is a widely used generally recognized as safe host for heterologous expression of proteins in both industry and academia. Recently, it has been shown to be a potentially good chassis host for the production of high-value pharmaceuticals and chemicals. Nevertheless, limited availability of selective markers and low efficiency of homologous recombination make this process difficult and time-consuming, particularly in the case of multistep biosynthetic pathways. Therefore, it is crucial to develop an efficient and marker-free multiloci gene knock-in method in P. pastoris.ResultsA non-homologous-end-joining defective strain (Δku70) was first constructed using the CRISPR–Cas9 based gene deficiency approach. It was then used as a parent strain for multiloci gene integration. Ten guide RNA (gRNA) targets were designed within 100 bp upstream of the promoters or downstream of terminator, and then tested using an eGFP reporter and confirmed as suitable single-locus integration sites. Three high-efficiency gRNA targets (PAOX1UP-g2, PTEF1UP-g1, and PFLD1UP-g1) were selected for double- and triple-locus co-integration. The integration efficiency ranged from 57.7 to 70% and 12.5 to 32.1% for double-locus and triple-locus integration, respectively. In addition, biosynthetic pathways of 6-methylsalicylic acid and 3-methylcatechol were successfully assembled using the developed method by one-step integration of functional genes. The desired products were obtained, which further established the effectiveness and applicability of the developed CRISPR–Cas9-mediated gene co-integration method in P. pastoris.ConclusionsA CRISPR–Cas9-mediated multiloci gene integration method was developed with efficient gRNA targets in P. pastoris. Using this method, multiple gene cassettes can be simultaneously integrated into the genome without employing selective markers. The multiloci integration strategy is beneficial for pathway assembly of complicated pharmaceuticals and chemicals expressed in P. pastoris.

Highlights

  • IntroductionLimited availability of selective markers and low efficiency of homologous recombination make this process difficult and time-consuming, in the case of multistep biosynthetic pathways

  • The present study aimed to develop a CRISPR–Cas9mediated genomic multiloci integration method in P. pastoris

  • Integration efficiency of single locus varies with Cas9 cleavage site and guide RNA (gRNA) The double strand break (DSB) caused by Cas9 is preferably repaired through NHEJ in P. pastoris

Read more

Summary

Introduction

Limited availability of selective markers and low efficiency of homologous recombination make this process difficult and time-consuming, in the case of multistep biosynthetic pathways. Protein expression by episomal plasmids has been reported in P. pastoris [13, 14], it requires integration of heterologous genes into the genome for stable expression [15]. This is because homologous recombination is usually inefficient in P. pastoris, which is a non-conventional yeast, even with homologous flanking regions over several hundred base pairs [16]. It is crucial to develop an efficient, rapid, and marker-free gene integration approach for biosynthetic pathway assembly in P. pastoris

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call